Term
 can ONLY modify the R group at the amino group on the bottom
 no substituents on the phenyl ring other than the amine (which has to be primary) drugs with the highest activity have a pKa close to that of PABA (pKa = 6.5). to do this you have to add EWGs on the R position, commonly heterocycles. |
|
Definition
|
|
Term
bacteriostatic effect (when used alone) folic acid inhibitors = antimetabolites
 folic acid PABA is very similar to sulfonamides. the drug will be inserted instead of the normal building block in the synthesis of folic acid.
 dihydropteroate synthetase will recognize the sulfonamide instead of the normal building block of folic acid synthesis |
|
Definition
|
|
Term
|
Definition
| as the pKa of sulfonamides increases, what happens to the activity of the drugs? |
|
|
Term
increased production of PABA alterations in the dihydropteroate synthetase reduced drug uptake (permeability barrier and/or efflux pumps) regulational changes in the target enzymes |
|
Definition
| mechanisms of bacterial resistance to sulfonamides |
|
|
Term
BROAD SPECTRUM small molecules so can cross porins and membranes urinary tract infections combinations - to reduce resistance |
|
Definition
| spectrum of activity of sulfonamides |
|
|
Term
well absorbed from the GI tract binding to plasma proteins (differs between different classes) pass into body fluids (peural, synovial, ocular, and cerebrospinal) excretion via renal |
|
Definition
| absorption, distribution, and excretion of sulfonamides |
|
|
Term
metabolism by acetylation of the para amino group:
 acetylsulfonamides are toxic: toxicity is related to the precipitation of the metabolite during excretion, can be prevented if patient drinks a lot of water to dissolve it better both sulfonamide and acetylsulfonamide are excreted renally sulfonamides are filtered and exhibit reabsorption metabolism by glucuronidation:
 less common than acetylation |
|
Definition
| metabolism of sulfonamides |
|
|
Term
hypersensitivity toxicity to the hematopoietic system toxicity to the urinary tract |
|
Definition
| adverse effects of sulfonamides |
|
|
Term
| long acting sulfonamides: sulfamethoxypiridazine and sulfamethoxydiazine |
|
Definition
| which class of sulfonamides are associated with Steven-Johnson syndrome? |
|
|
Term
very long acting sulfonamides: sulfadoxine administered once weekly |
|
Definition
| what class of sulfonamides is used in combination with pyrimethamine for prophylaxis of malaria? |
|
|
Term
inhibitor of dihydrofolate reductase used for urinary tract infections in combination with sulfonamides
 trimethoprim binds to the enzyme in the last step of the synthesis of folic acid |
|
Definition
MOA of trimethoprim
 |
|
|
Term
available PO and IV volume of distribution greater than sulfonamides excreted in the urine metabolism by acetylation |
|
Definition
| pharmacology of trimethoprim |
|
|
Term
GI upset folate deficiency may occur in some patients CONTRAINDICATED in pregnant women to avoid folate deficiency trimethoprim and sulfonamides are SELECTIVE b/c humans do not synthesize folate, we get it from our diets. |
|
Definition
| adverse effects of trimethoprim |
|
|
Term
plasmid-encoded TMP resistance chromosomal TMP resistance |
|
Definition
| bacterial resistance of trimethoprim |
|
|
Term
bactericidal broad spectrum urinary tract infections, respiratory tract infections, GI tract infections |
|
Definition
| spectrum of trimethoprim/sulfonamide combinations |
|
|